# ResMed completes $225M acquisition of Propeller Health

ResMed completed its acquisition of Propeller Health, a digital therapeutics company for COPD and asthma, for $225 million in cash. Propeller will operate as a standalone business within ResMed's Respiratory Care portfolio.

- Type: Acquisition
- Announced: 2019-01-07
- Where: United States
- Value: $225.0M
- Status: completed
- Products: digital therapeutics, connected health solutions for COPD and asthma
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ResMed](https://endata.com/companies/35402.md) (acquirer)
- [Propeller Health](https://endata.com/companies/36547.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/resmed-completes-225-million-acquisition-of-propeller-health), 2019-01-07: "I’m excited to welcome Propeller, a fellow digital health innovator and high-performing company, into the ResMed family."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.